High Plasma Homocysteine: A Risk Factor for Arterial and Venous Thrombosis in Patients with Normal Coagulation Profiles
- 1 October 1997
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/hemostasis
- Vol. 3 (4) , 239-244
- https://doi.org/10.1177/107602969700300404
Abstract
A high plasma homocysteine concentration is associated with premature vascular disease and thrombosis. The association between high homocysteine concentrations and thrombosis in patients with a normal coagulation profile is unknown. Sixty adults (37 men and 23 women, mean age 46 years) with documented thrombosis were compared with age-and sex-matched controls. Those with risk factors for thrombosis or abnormal coagulation profiles were excluded. Homocysteine concentrations were higher in cases than controls (21.8 ± 13.8 vs 11.0 ± 4.7 μmol/L, p < 0.001). A cut point for defining high homocysteine concentrations was determined at 13 μmol/L and conferred an increased odds ratio for thrombosis overall (7.8, 95% CI 3.0-20.2, p < 0.001) as well as in men (8.9, 95% CI 3.0-26.1; p < 0.001) and women (37.8, 95% CI 6.5-213.9; p < 0.01). A high plasma homocysteine is a risk factor for thrombosis in patients with a normal coagulation profile. This common abnormality should be sought in patients with otherwise unexplained thrombotic episodes. Key Words: Homocysteine—Thrombosis—Clotting.Keywords
This publication has 38 references indexed in Scilit:
- Plasma Homocysteine Levels in Patients With Deep Venous ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism.Journal of Clinical Investigation, 1993
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985
- The pathogenesis of coronary artery disease. A possible role for methionine metabolism.Journal of Clinical Investigation, 1976
- Metabolic Abnormalities Detected in a Survey of Mentally Backward Individuals in Northern IrelandArchives of Disease in Childhood, 1962